Nicolas Geis

Name	Nicolas Geis
Education/Training	B.Sc. Chemistry – University Freiburg i. Br. M.Sc. Pharmaceutical Science – University Freiburg i. Br.
Start of PhD Thesis and Group	10/2020, Prof. Matthias Eder
Subject of Thesis	Reduction of dose-limiting salivary gland uptake in endoradiotherapy of prostate carcinoma
Research Interests	Radiochemistry, molecular imaging, endoradiotherapy, pharmacokinetics & -dynamics, personalised medicine, drug development
Methods and Techniques	Radiochemistry, organic chemistry, peptide synthesis & purification, HPLC, in vivo experiments, Cell culture & assays, PET-imaging
Publications	El Fakiri, M.; Geis, N.M.; Ayada, N.; Eder, M.; Eder, A.-C. PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives. Cancers 2021, 13, 3967. https://doi.org/10.3390/cancers13163967 El Fakiri M, Ayada N, Müller M, Hvass L, Gamzov TH, Clausen AS, Geis NM, Steinacker N, Hansson E, Lindegren S, Aneheim E, Jensen H, Eder AC, Jensen AI, Poulie CBM, Kjaer A, Eder M, Herth MM. Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer. J Nucl Med. 2024 Apr 1;65(4):593-599. doi: 10.2967/jnumed.123.267043.
Contact	nicolas.geis[at]uniklinik-freiburg.de